ABL Diagnostics Logo

ABL Diagnostics

Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.

ABLD | PA

Overview

Corporate Details

ISIN(s):
FR0000063034 (+1 more)
LEI:
9695002UO0UHM0VKRH38
Country:
France
Address:
72 ROUTE DE THIONVILLE, 57140 WOIPPY
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

ABL Diagnostics is a medical technology company that develops, manufactures, and commercializes end-to-end diagnostic solutions for infectious diseases. The company specializes in genotyping, utilizing sequencing technologies such as Sanger and Next-Generation Sequencing (NGS), alongside PCR-based tests. Its product portfolio includes diagnostic assays (e.g., UltraGene), proprietary analysis software, data hosting services, and laboratory automation systems. ABL Diagnostics provides integrated decision support tools for virology and microbiology laboratories, clinicians, and researchers, aiming to improve disease management and support medical progress.

Social Media

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ABL Diagnostics and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-25 18:13
Post-Annual General Meeting Information
Acquisition ou cession des actions de l'émetteur / Descriptif du programme de r…
French 128.9 KB
2025-05-07 18:40
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 4.5 MB
2025-05-06 18:00
Earnings Release
Informations privilégiées / Communiqué sur comptes, résultats
French 186.6 KB
2025-05-06 17:26
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 4.5 MB
2024-11-18 18:16
Report Publication Announcement
Rapports financiers et d'audit semestriels/examens réduits / Modalités de mise …
French 139.5 KB
2024-11-18 18:15
Interim Report
Rapports financiers et d'audit semestriels/examens réduits / Rapport financier …
French 1.8 MB
2024-08-30 18:00
Pre-Annual General Meeting Information
Modalités de mise à disposition des documents préparatoires à l'AG
French 237.1 KB
2024-08-26 14:30
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-08-05 18:00
Declaration of Voting Results & Voting Rights Announcements
Total du nombre de droits de vote et du capital / Information relative au nombr…
French 197.7 KB
2024-07-31 22:36
Report Publication Announcement
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rap…
French 144.2 KB
2024-07-31 21:38
Annual Report
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-07-31 21:38
Annual Report (ESEF)
Rapports financiers et d'audit annuels / Rapport financier annuel
French 9.8 MB
2024-07-03 18:00
Capital/Financing Update
Acquisition ou cession des actions de l'émetteur / Information relative au cont…
French 234.8 KB
2024-07-01 18:00
Earnings Release
Informations privilégiées / Information sur chiffre d’affaires annuel
French 216.8 KB
2024-05-29 18:44
Report Publication Announcement
Informations privilégiées / Communiqué sur comptes, résultats
French 116.5 KB

Automate Your Workflow. Get a real-time feed of all ABL Diagnostics filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ABL Diagnostics via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Theradiag Logo
Develops IVD tests for biotherapy monitoring in autoimmune diseases and oncology.
France ALTER
TISSUE REGENIX GROUP PLC Logo
Develops regenerative biological products for orthopaedic and dental markets.
United Kingdom TRX
Developing disruptive spinal fixation devices for the vertebral surgery market.
United Kingdom N/A
Ulisse Biomed Logo
Provides a portable platform for rapid point-of-need genetic analysis and diagnostics.
Italy UBM
Viromed Medical Logo
Develops cold plasma tech for infection control, wound care, and air disinfection for healthcare.
Germany VMED
Vitrolife Logo
Global provider of medical devices and genetic testing services for the IVF treatment journey.
Sweden VITR
Xvivo Perfusion Logo
Develops ex-vivo machine perfusion systems to improve organ viability for transplantation.
Sweden XVIVO
Ypsomed Holding AG Logo
Develops injection systems for self-medication, partnering with pharma and biotech firms.
Switzerland YPSN

Talk to a Data Expert

Have a question? We'll get back to you promptly.